1592003-71-8Relevant articles and documents
Synthesis, docking and in vitro anticancer evaluation of some new benzopyrone derivatives
El-Ansary, Sohair L.,Hussein, Mohammed M.,Abdel Rahman, Doaa E.,Abdel Ghany, Lina M.A.
, p. 50 - 66 (2014/03/21)
The synthesis of some new 3-alkyl-7-hydroxy-4-methyl-8-substituted-1H- benzopyran-2-ones, 6-alkyl-7-methyl-2-substituted amino-5H-pyrano[6,5-e] benzoxazol-5-ones, 7-alkyl-8-methyl-3-substituted-2,6-dihydropyrano[6,5-f]-1,4- benzoxazin-6-ones, 7,8-disubstituted-3-ethyl-4-methyl-1H-benzopyran-2-ones and 3-alkyl-4-methyl-7-substituted-1H-benzopyran-2-ones were described. Fourteen compounds were selected by National Cancer Institute (NCI), Bethesda, and evaluated for their in vitro anticancer activity in the full NCI 60 cell lines panel assay by a single dose test. Compounds 4a, 18a, 18b and 23a were found to be broad-spectrum antitumors showing effectiveness toward numerous cell lines that belong to different tumor subpanels. Furthermore, docking studies were undertaken to gain insight into the possible binding mode of these compounds with the binding site of the casein kinase II (CK2) enzyme which is involved in cell survival and proliferation through a number of downstream effectors.
